Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,200
Closed -$6K 3995
2019
Q4
$6K Hold
1,200
﹤0.01% 2912
2019
Q3
$1K Buy
+1,200
New +$19.8K ﹤0.01% 3657
2018
Q4
Sell
-13,900
Closed -$4K 3910
2018
Q3
$4K Buy
13,900
+13,500
+3,375% +$589K ﹤0.01% 3137
2018
Q2
$6K Sell
400
-1,300
-76% -$57.3K ﹤0.01% 2966
2018
Q1
$20K Buy
+1,700
New +$52.1K ﹤0.01% 2284
2017
Q4
Sell
-1,200
Closed -$11K 4876
2017
Q3
$11K Sell
1,200
-900
-43% -$15.1K ﹤0.01% 3700
2017
Q2
$11K Hold
2,100
﹤0.01% 4045
2017
Q1
$2K Sell
2,100
-15,200
-88% -$155K ﹤0.01% 5367
2016
Q4
$5K Buy
+17,300
New +$149K ﹤0.01% 4861

Other funds holding AXGN

Cutler Group's AXGN Position: Q1 2022 in Review

Cutler Group sold out of Axogen (AXGN) in Q1 2022, closing a stake of 1,200 shares — an estimated $11K sold.

Cutler Group first reported a position in AXGN in Q3 2016 and held it in 12 quarters. The position peaked at $115K in Q2 2018. 132 funds tracked by Wall St. Rank hold AXGN as of Q1 2022.

  • Cutler Group reported no remaining Axogen position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 1,200 Axogen shares in Q1 2022, an estimated $11K.
  • Cutler Group first reported a position in Axogen in Q3 2016 and held it in 12 quarters.
  • Cutler Group's Axogen position peaked at $115K in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Axogen as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.